The approval broadens Vetmedin’s label, which already covers management of mild to severe congestive heart failure in dogs with clinical myxomatous mitral valve disease or dilated cardiomyopathy.
Discover how the FDA's approval of Vetmedin, the first drug to delay congestive heart failure in dogs, is transforming canine ...
The MarketWatch News Department was not involved in the creation of this content.-- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimob ...
Doctors are examining ways to prevent heart disease, stroke, and cardiovascular risk factors through treating other related illnesses earlier.
Jan 19 () - Pharmaceutical company Boehringer Ingelheim said on Monday the U. Food and Drug Administration had approved its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results